Cells from genetically different individuals of the same species to be used for CELL- AND TISSUE-BASED THERAPY; ADOPTIVE CELL TRANSFER; or ADOPTIVE IMMUNOTHERAPY.
Phase 3 trials (5)
Phase 2 trials (13)
Phase 1 trials (3)